Abstract

Edgewell Personal Care will report fiscal Q3 2026 results on August 05, 2026 Pre-Market, with investors watching revenue momentum, margins, and EPS against a soft consumer backdrop.

Market Forecast

For the current fiscal quarter, the company’s revenue is projected at 576.47 million US dollars, implying a 12.18% year-over-year decline, with an EBIT estimate of 52.65 million and EPS estimate of 0.62, both implying declines of 34.85% and 38.62% year over year, respectively. Consensus implies ongoing pressure on profitability, with year-over-year declines expected in revenue and earnings; if disclosed, the market will focus on gross margin resilience and net margin progression, though no explicit margin forecasts are available.

The company’s main businesses are wet shaving and sun and skin care, which together comprise the revenue base, with wet shaving at 294.10 million US dollars and sun and skin care at 225.40 million US dollars in the last reported quarter. The most promising segment near term is sun and skin care, where seasonal demand and distribution gains can support stabilization even as pricing normalizes; a sustained recovery would hinge on maintaining shelf space and promotional efficiency.

Last Quarter Review

In the last reported quarter, revenue was 519.50 million US dollars, gross profit margin was 43.43%, GAAP net profit attributable to the parent company was -10.60 million US dollars with a net margin of -2.04%, and adjusted EPS was 0.60, while revenue declined 10.54% year over year and adjusted EPS decreased 31.03% year over year. A key highlight was disciplined cost control that helped deliver EBIT of 49.40 million US dollars despite top-line pressure, outpacing prior estimates. By business, wet shaving contributed 294.10 million US dollars and sun and skin care 225.40 million US dollars; management emphasized mixed performance with relatively firmer sell-through in sun protection entering peak season, though exact growth rates were not disclosed.

Current Quarter Outlook (with major analytical insights)

Main business: Wet shaving

Wet shaving remains the largest revenue contributor and the backbone of the company’s cash generation, though the category faces category-wide pricing normalization after multiple rounds of inflationary price increases. Sell-in is likely to be influenced by retailer inventory prudence and promotional resets heading into late-summer resets. ASPs may moderate versus the prior year, making volume and mix improvements more critical to sustain margin dollars. Given the revenue decline expected this quarter, investors will parse shipment timing effects and any trade-down dynamics within razors and blades. Stabilization could come from innovation cycles focused on comfort and skin sensitivity, but the payoff depends on merchandising and shelf execution with key retail partners.

Most promising business: Sun and skin care

Sun and skin care has the clearest seasonal lift in fiscal Q3 due to the Northern Hemisphere summer, positioning it for relative outperformance versus wet shaving. The quarter’s forecasted earnings compression suggests gross-to-net pressure is still a factor, yet category elasticity appears more favorable than blades, aided by replenishment and new formats. Distribution wins and omnichannel share gains can offset promotional intensity, particularly in sport, baby, and mineral-based sun care. The essential nature of sun protection also supports baseline demand, but weather variability and promotional overlap with competitors can swing weekly sell-through, so execution in retail endcaps and digital channels remains pivotal. If the segment sustains positive sell-through into late July, it can be a key buffer for consolidated revenue.

Stock price drivers this quarter

The stock’s near-term reaction is likely to be driven by the spread between revenue/EBIT trends and expectations, with particular focus on gross margin versus last quarter’s 43.43% as input-cost tailwinds and freight normalization cycle through. Guidance quality and commentary on retailer inventory levels will be scrutinized, since shipment timing can exaggerate quarterly volatility. FX exposure and lapping of prior price increases may suppress reported growth rates; clear signals on price, mix, and volume decomposition would help investors recalibrate run-rate EPS. Working capital discipline and free cash flow conversion could mitigate earnings pressure and support valuation, while any mention of incremental productivity programs may be viewed favorably if they preserve brand support.

Analyst Opinions

Analyst commentary over the past six months skews cautious-to-constructive, with a majority leaning bullish on margin repair and second-half normalization despite near-term top-line pressure. Several noted that the forecast implies revenue down 12.18% and EPS down 38.62% year over year for the quarter, setting a bar that could be beat if sun care trends hold and cost actions remain on track. Coverage highlighting disciplined expense control and potential for gross margin stabilization suggests upside risk to the estimates if promotional intensity does not escalate. The consensus view expects management to reiterate a measured path toward profit improvement into fiscal Q4, with sun and skin care performing as a relative bright spot and wet shaving stabilizing as innovation rolls out. Overall, bullish voices anticipate a constructive print relative to subdued expectations, with attention focused on gross margin trajectory and updated commentary on pricing and retailer inventory normalization.